How a Structured Transition Program Could Help Young People Move From Teen to Adult Diabetes Care
Researchers are testing a new approach to help teenagers with Type 1 diabetes prepare for the shift to adult healthcare. Early results aim to show whether extra support during this critical handoff improves readiness and health outcomes.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Many teens with Type 1 diabetes feel unprepared when moving from pediatric to adult care, which can lead to gaps in treatment and worse health outcomes.
- The COCCOS study is testing a structured program with four visits over 13–16 months designed to build independence and prepare young people for the transition.
- Researchers will measure success by looking at transition readiness, medication adherence, mental health, quality of life, and whether the program is cost-effective.
- This is a real-world study in two Belgian hospitals—not a small lab experiment—which means the results could apply to many healthcare systems.
The Gap in Transition Care
Around age 18, young people with Type 1 diabetes typically move from pediatric clinics—where doctors specialize in treating children—to adult endocrinology practices. This shift sounds straightforward, but many teens and young adults report feeling unprepared. Without the right support, patients may miss appointments, struggle to manage their own care, or experience gaps in treatment.
These disruptions can have real consequences: missed clinic visits, medication mistakes, and worsening blood sugar control. Mental health can suffer too. Yet despite decades of research showing this is a problem, many healthcare systems still offer little formal help to bridge this gap.
A Co-Designed Transition Program
The COCCOS project developed a new transition program by listening to what young people with chronic conditions actually need. The program isn't a one-time conversation; it's four structured clinic visits spread across 13 to 16 months. Each visit focuses on building practical skills, encouraging independence in self-care, and planning for continuity of treatment.
The program is being tested in two university hospitals in Belgium, with young people aged 17–18 who have Type 1 diabetes, asthma, or obesity. Half receive the new structured program (intervention group), while half receive standard transition care (control group). This design allows researchers to directly compare outcomes.
What Researchers Will Measure
The study's main goal is to see whether the COCCOS program improves how ready young people feel for the transition. Readiness will be measured using a validated tool called the Transition Readiness Assessment Questionnaire.
But readiness is only part of the story. Researchers are also tracking medication adherence (whether teens actually take their insulin and other medicines as prescribed), mental health, quality of life, and empowerment—the sense of being in control of one's own care. Data will be collected at the start, at the time of transfer to adult care, and again four months later.
A key question is cost-effectiveness: Does the extra structure and support save money and improve health enough to justify its cost? Researchers will analyze this from a healthcare system perspective.
Looking Beyond the Numbers
Numbers tell only part of the story. The COCCOS team is also examining how well the program actually works in real clinics—whether staff deliver it as planned, whether young people find it acceptable, and what barriers or helpful factors emerge in each setting. They'll do this through observations, surveys, and interviews.
This mixed-methods approach is important because a program that looks good on paper might not fit smoothly into every hospital or work for every patient. Understanding why the program succeeds or struggles will help other healthcare systems decide whether and how to adopt it.
What Comes Next
The COCCOS study is registered on ClinicalTrials.gov and is expected to yield results in the coming years. If the structured transition program proves effective and cost-effective, it could become a model for helping young people with Type 1 diabetes—and other chronic conditions—navigate one of the most disruptive changes in their healthcare journey.
For now, if you're a parent or young person facing this transition, this research highlights why asking your healthcare team about transition preparation is important. Not every clinic offers a structured program yet, but the evidence is growing that deliberate, supported transitions lead to better long-term outcomes.
Evidence label
Source: PloS one. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Living With T1DCorrection to "The Use of an Automated Insulin Delivery System Is Associated With a Reduction in Diabetes Distress and Improvement in Quality of Life in People With Type 1 Diabetes".PubMed indexed literature
- Living With T1DA New Class of Biologics Could Change How We Treat Type 1 DiabetesPubMed indexed literature
- Living With T1DMenopause and Type 1 Diabetes: What Women Need to KnowPubMed indexed literature
- Living With T1DThe Promise and Challenge of Oral Insulin: Where the Research StandsPubMed indexed literature
- Living With T1DYour Glucose Range May Not Be the Guideline Range—And That's Worth UnderstandingPubMed indexed literature
- Living With T1DMetformin in Pregnancy With Type 1 Diabetes: What Early Data ShowsPubMed indexed literature